SE431216B - Forfarande for framstellning av 1n-(alfa-hydroxi-omega-amino-alkanoyl)-6 721n-metyl-3 721, 4 721-dideoxikanamycin b eller farmaceutiskt godtagbara syraadditionssalter derav - Google Patents

Forfarande for framstellning av 1n-(alfa-hydroxi-omega-amino-alkanoyl)-6 721n-metyl-3 721, 4 721-dideoxikanamycin b eller farmaceutiskt godtagbara syraadditionssalter derav

Info

Publication number
SE431216B
SE431216B SE7511229A SE7511229A SE431216B SE 431216 B SE431216 B SE 431216B SE 7511229 A SE7511229 A SE 7511229A SE 7511229 A SE7511229 A SE 7511229A SE 431216 B SE431216 B SE 431216B
Authority
SE
Sweden
Prior art keywords
dideoxicanamycine
alfa
alkanoyl
omega
hydroxy
Prior art date
Application number
SE7511229A
Other languages
English (en)
Other versions
SE7511229L (sv
Inventor
H Umezawa
K Maeda
S Kondo
S Umezawa
Original Assignee
Microbial Chem Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Microbial Chem Res Found filed Critical Microbial Chem Res Found
Publication of SE7511229L publication Critical patent/SE7511229L/sv
Publication of SE431216B publication Critical patent/SE431216B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20Carbocyclic rings
    • C07H15/22Cyclohexane rings, substituted by nitrogen atoms
    • C07H15/222Cyclohexane rings substituted by at least two nitrogen atoms
    • C07H15/226Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings
    • C07H15/234Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings attached to non-adjacent ring carbon atoms of the cyclohexane rings, e.g. kanamycins, tobramycin, nebramycin, gentamicin A2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Physical Vapour Deposition (AREA)
SE7511229A 1974-10-08 1975-10-07 Forfarande for framstellning av 1n-(alfa-hydroxi-omega-amino-alkanoyl)-6 721n-metyl-3 721, 4 721-dideoxikanamycin b eller farmaceutiskt godtagbara syraadditionssalter derav SE431216B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP49115199A JPS5148634A (en) 1974-10-08 1974-10-08 Taiseikinnyukona 11nn * arufua hidorokishi omega aminoashiru * 6**nn mechiru 3* *hh jideokishikanamaishin b no seizoho

Publications (2)

Publication Number Publication Date
SE7511229L SE7511229L (sv) 1976-04-09
SE431216B true SE431216B (sv) 1984-01-23

Family

ID=14656799

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7511229A SE431216B (sv) 1974-10-08 1975-10-07 Forfarande for framstellning av 1n-(alfa-hydroxi-omega-amino-alkanoyl)-6 721n-metyl-3 721, 4 721-dideoxikanamycin b eller farmaceutiskt godtagbara syraadditionssalter derav

Country Status (16)

Country Link
JP (1) JPS5148634A (sv)
BE (1) BE834236A (sv)
CA (1) CA1050537A (sv)
CH (1) CH615685A5 (sv)
DE (1) DE2543535C3 (sv)
DK (1) DK148262C (sv)
FR (1) FR2287233A1 (sv)
GB (1) GB1475481A (sv)
HU (1) HU173702B (sv)
IE (1) IE42354B1 (sv)
LU (1) LU73533A1 (sv)
NL (1) NL181503C (sv)
SE (1) SE431216B (sv)
SU (1) SU965359A3 (sv)
YU (1) YU39659B (sv)
ZA (1) ZA756291B (sv)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57175198A (en) * 1981-04-20 1982-10-28 Microbial Chem Res Found 1-n-acyl derivative of 5,3,4-trideoxy-6-n-methylkanamycin b and their preparation
JPS60179468U (ja) * 1984-05-11 1985-11-28 大成プラス株式会社 多色スタンプ
DE102006004062A1 (de) 2006-01-28 2007-08-09 Degussa Gmbh Kautschukmischungen
RU2458931C2 (ru) 2006-06-02 2012-08-20 Мейдзи Сейка Фарма Ко., Лтд. Новые аминогликозидные антибиотики

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4001208A (en) * 1972-10-06 1977-01-04 Zaidan Hojin Biseibutsu Kagaku Kenkyo Kai 1-N-[(S)-α-hydroxy-ω-aminoacyl]

Also Published As

Publication number Publication date
NL7511662A (nl) 1976-04-12
YU39659B (en) 1985-03-20
DE2543535B2 (de) 1977-10-13
AU8518975A (en) 1977-03-31
DE2543535A1 (de) 1976-04-22
IE42354L (en) 1976-04-08
FR2287233A1 (fr) 1976-05-07
DE2543535C3 (de) 1978-06-01
CA1050537A (en) 1979-03-13
JPS5653558B2 (sv) 1981-12-19
YU253075A (en) 1982-05-31
SU965359A3 (ru) 1982-10-07
ZA756291B (en) 1976-06-30
IE42354B1 (en) 1980-07-30
NL181503C (nl) 1987-09-01
DK148262B (da) 1985-05-20
FR2287233B1 (sv) 1978-11-10
LU73533A1 (sv) 1976-08-19
SE7511229L (sv) 1976-04-09
DK148262C (da) 1986-02-10
GB1475481A (en) 1977-06-01
NL181503B (nl) 1987-04-01
DK451475A (da) 1976-04-09
CH615685A5 (en) 1980-02-15
HU173702B (hu) 1979-07-28
BE834236A (fr) 1976-04-06
JPS5148634A (en) 1976-04-26

Similar Documents

Publication Publication Date Title
SE385585B (sv) Forfarande for framstellning av 1-alkyl-1,4-dihydro-4-oxo-3-kinolinkarboxylsyraderivat
AR209607A1 (es) Procedimiento de preparacion de derivados de acido 2,3-d oxo-1-piperazino-carbonilamino-acetamido-penicilanico o 2,3-dioxo-1-piperazinocarbonilamino-acetamido-delta3-cefem-4-carboxilico
SE425392B (sv) Forfarande for framstellning av nya 5,9-beta-disubstituerade 2-tetrahydrofurfuryl-6,7-bensomorfaner eller deras syraadditionssalter
DK153397C (da) Analogifremgangsmaade til fremstilling af 1,3,4-trisubstituerede 4-arylpiperidiner eller farmaceutisk acceptable syreadditionssalte deraf
SE7710600L (sv) Forfarande for framstellning av 1,3-bensoxazoler
DK133899B (da) Analogifremgangsmåde til fremstilling af benzofuranderivater eller farmaceutisk acceptable syreadditionssalte deraf.
DK138536B (da) Analogifremgangsmåde til fremstilling af 1-naphthalen- eller 4-quinolincarboxamider eller farmaceutisk acceptable syreadditionssalte deraf.
SE7504842L (sv) Forfarande for framstellning av adeninderivat..
SE402009B (sv) Forfarande for framstellning av 9-desoxi-prosta-5,9,(10),13-triensyraderivat
DK137382B (da) Analogifremgangsmåde til fremstilling af 2,2-diaryl-4-(4'-aryl-4'-hydroxy-piperidin)butyramider eller syreadditionssalte deraf.
SE420716B (sv) Forfarande for framstellning av nya 2-aminometyl-4,6-diahalogenofenolderivat
SE431451B (sv) Forfarande for framstellning av 2,3-dihydroxipropoxikinoliner eller -isokinoliner
SE431216B (sv) Forfarande for framstellning av 1n-(alfa-hydroxi-omega-amino-alkanoyl)-6 721n-metyl-3 721, 4 721-dideoxikanamycin b eller farmaceutiskt godtagbara syraadditionssalter derav
DK131857B (da) Analogifremgangsmåde til fremstilling af 4-hydroxymethyl-1-phthalazonderivater eller syreadditionssalte deraf.
DK143197C (da) Analogifremgangsmaade til fremstilling af 5,7-dihydroxy-tetrahydroisoquinoliner eller farmaceutisk acceptable syreadditionssalte deraf
DK135574B (da) Fremgangsmåde til fremstilling af benzylaminderivater eller fysiologisk anvendelige syreadditionssalte heraf.
DK137044B (da) Analogifremgangsmåde til fremstilling af 4,4-diphenylhexahydroazepinderivater eller syreadditionssalte deraf.
SE7700792L (sv) Forfarande for framstellning av n,n'-diklor-isoftalsyraamid
DK138540B (da) Analogifremgangsmåde til fremstilling af benzhydryloxyalkylaminderivater eller farmaceutisk acceptable syreadditionssalte deraf.
NO144488C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme 8,12-diisoprostansyre-derivater
DK138320B (da) Analogifremgangsmåde til fremstilling af 1,4-benzodiazepinderivater eller farmaceutisk anvendelige syreadditionssalte deraf.
DK135374B (da) Analogifremgangsmåde til fremstilling af 2,4-diamino-5-benzylpyrimidiner eller syreadditionssalte deraf.
DK135423B (da) Analogifremgangsmåde til fremstilling af antirhinovirale 2,5-bis-substituerede amino-1,3,4,-thiadiazoler eller farmaceutisk acceptable syreadditionssalte deraf.
DK138266B (da) Analogifremgangsmåde til fremstilling af basiske derivater af 1-aryl-2-oxo-2,4,5,6,7,7a-hexahydroindoler eller syreadditionssalte deraf.
DK139943B (da) Fremgangsmåde til fremstilling af triazolo(4,3a)(1,4)benzodiazepin-5N-oxydderivater eller syreadditionssalte deraf.

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7511229-2

Effective date: 19930510

Format of ref document f/p: F